Dpcr And Qpcr Market Scope And Analysis

Report Code : TIPHE100000817
Category : Life Sciences

Status : Published
No. of Pages : 159

Buy Now

dPCR and qPCR Market Scope and Key Players Analysis by 2030

Buy Now

dPCR and qPCR Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 8,976.99 Million
Market Size by 2030	US$ 18,230.74 Million
Global CAGR (2022 - 2030)	9.30%
Historical Data	2020-2021
Forecast period	2023-2030
Segments Covered	By Treatment Quantitative PCR Digital PCR By Product Reagents & Consumables Instruments Software & Services By Application Research Application Clinical Application Forensic Application By End User Hospitals and Diagnostic Centers Pharmaceutical and Biotechnology Companies Research Laboratories and Academic Institutes Forensic Laboratories Clinical Research Organizations
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Abbott Laboratories Thermo Fisher Scientific Inc Takara Bio Inc Qiagen NV Standard Biotools Inc Lepu Medical Technology Beijing Co Ltd F Hoffmann la Roche Ltd Bio rad Laboratories Inc Agilent Technologies Inc

dPCR and qPCR Market News and Recent Developments

The dPCR and qPCR market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the dPCR and qPCR market are listed below:

QIAGEN NV announced the expansion of its digital PCR (dPCR) offering to develop cell and gene therapies in the biopharma industry. The company has partnered with Niba Labs to offer customized digital PCR assay design services to biopharma customers and also launched the new CGT Viral Vector Lysis Kit that enables a standardized workflow from cell lysates to absolute and precise quantification of viral titers for multiple serotypes. (Source: QIAGEN NV, Press Release, July 2023)
Roche and its subsidiary TIB Molbiol have developed three unique LightMix Modular Virus kits in response to recent monkeypox virus concerns. Multiple clusters of the monkeypox virus have been reported within the past two weeks in several European countries and North America, regions where the virus is not commonly found. (Source: Roche, Press Release, May 2023)

dPCR and qPCR Market Report Coverage and Deliverables

The “dPCR and qPCR Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

dPCR and qPCR market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
dPCR and qPCR market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
dPCR and qPCR market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the dPCR and qPCR market
Detailed company profiles